Metrics to compare | 6814 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6814PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.5x | −89.1x | −0.3x | |
PEG Ratio | −1.97 | −9.58 | 0.00 | |
Price/Book | 4.1x | 7.5x | 2.6x | |
Price / LTM Sales | 4.6x | 158.5x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 66.6% | |
Fair Value Upside | Unlock | −27.9% | 9.1% | Unlock |
Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.